Terms: = Prostate cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
34 results:
1. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer.
Zhang Z; Cai Q; Wang J; Yao Z; Ji F; Hang Y; Ma J; Jiang H; Yan B; Zhanghuang C
Sci Rep; 2023 Oct; 13(1):17719. PubMed ID: 37853026
[TBL] [Abstract] [Full Text] [Related]
3. 5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder cancer: United States insurance claims data.
Del Giudice F; Belladelli F; Glover F; Basran S; Li S; Mulloy E; Pradere B; Soria F; Krajewski W; Nair R; Muncey W; Seranio N; Eisenberg ML
World J Urol; 2023 Oct; 41(10):2783-2791. PubMed ID: 37548746
[TBL] [Abstract] [Full Text] [Related]
4. Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Seesaghur A; Egger P; Warden J; Abbasi A; Levick B; Riaz M; McMahon P; Thompson M; Cheeseman S
BMJ Open; 2023 May; 13(5):e069214. PubMed ID: 37156580
[TBL] [Abstract] [Full Text] [Related]
5. Are high-risk prostate cancer patients being treated equally? The impact of PSA.
Kord E; Ferenczi B; DiNatale RG; Daily A; Koenig H; Frankel J; Jung N; Flores JP; Porter C
Urol Oncol; 2023 Apr; 41(4):204.e17-204.e25. PubMed ID: 36918337
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System.
Wu B; Shen P; Yin X; Yu L; Wu F; Chen C; Li J; Xu T
Br J Clin Pharmacol; 2023 Feb; 89(2):440-448. PubMed ID: 35349180
[TBL] [Abstract] [Full Text] [Related]
7. Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer.
Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Hoeh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
Prostate; 2022 May; 82(6):740-750. PubMed ID: 35226380
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Significance and Underlying Mechanisms of CELSR3 in Metastatic prostate cancer Based on Immunohistochemistry, Data Mining, and
Sun Y; Chen G; He J; Li JX; Gan XY; Ji SF; Huang Y; Chen XH; He ML; Huang ZG
Cancer Biother Radiopharm; 2022 Aug; 37(6):466-479. PubMed ID: 34582697
[No Abstract] [Full Text] [Related]
9. Assessment of Modifiable Factors for the Association of Marital Status With cancer-Specific Survival.
Chen ZH; Yang KB; Zhang YZ; Wu CF; Wen DW; Lv JW; Zhu GL; Du XJ; Chen L; Zhou GQ; Liu Q; Sun Y; Ma J; Xu C; Lin L
JAMA Netw Open; 2021 May; 4(5):e2111813. PubMed ID: 34047792
[TBL] [Abstract] [Full Text] [Related]
10. BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma.
Wang X; Wang C; Yan G; Kang Y; Sun G; Wang S; Zou R; Sun H; Zeng K; Song H; Liu W; Sun N; Liu W; Zhao Y
EBioMedicine; 2020 Mar; 53():102685. PubMed ID: 32113162
[TBL] [Abstract] [Full Text] [Related]
11. Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials.
Guo W; Sun YC; Bi JQ; He XY; Xiao L
BMC Cancer; 2019 Nov; 19(1):1063. PubMed ID: 31703647
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in prostate cancer.
Aghdam AM; Amiri A; Salarinia R; Masoudifar A; Ghasemi F; Mirzaei H
Crit Rev Eukaryot Gene Expr; 2019; 29(2):127-139. PubMed ID: 31679268
[TBL] [Abstract] [Full Text] [Related]
13. Cost-Effectiveness of Active Surveillance, Radical prostatectomy and External Beam Radiotherapy for Localized prostate cancer: An Analysis of the ProtecT Trial.
Sharma V; Wymer KM; Borah BJ; Barocas DA; Thompson RH; Karnes RJ; Boorjian SA
J Urol; 2019 Nov; 202(5):964-972. PubMed ID: 31112105
[TBL] [Abstract] [Full Text] [Related]
14. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
[TBL] [Abstract] [Full Text] [Related]
15. A Deep Learning-Based Approach for the Detection and Localization of prostate cancer in T2 Magnetic Resonance Images.
Alkadi R; Taher F; El-Baz A; Werghi N
J Digit Imaging; 2019 Oct; 32(5):793-807. PubMed ID: 30506124
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines.
Eroğlu C; Seçme M; Bağcı G; Dodurga Y
Tumour Biol; 2015 Dec; 36(12):9437-46. PubMed ID: 26124008
[TBL] [Abstract] [Full Text] [Related]
17. Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.
Hegarty SE; Hyslop T; Dicker AP; Showalter TN
PLoS One; 2015; 10(2):e0118430. PubMed ID: 25706657
[TBL] [Abstract] [Full Text] [Related]
18. Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines.
Olivan M; Rigau M; Colás E; Garcia M; Montes M; Sequeiros T; Regis L; Celma A; Planas J; Placer J; Reventós J; de Torres I; Doll A; Morote J
Biomed Res Int; 2015; 2015():762178. PubMed ID: 25649906
[TBL] [Abstract] [Full Text] [Related]
19. Effect of depression on diagnosis, treatment, and mortality of men with clinically localized prostate cancer.
Prasad SM; Eggener SE; Lipsitz SR; Irwin MR; Ganz PA; Hu JC
J Clin Oncol; 2014 Aug; 32(23):2471-8. PubMed ID: 25002728
[TBL] [Abstract] [Full Text] [Related]
20. A competing risk analysis of cancer-specific mortality of initial treatment with radical prostatectomy versus radiation therapy in clinically localized high-risk prostate cancer.
Lee JY; Cho KS; Kwon JK; Jeh SU; Kang HW; Diaz RR; Ham WS; Koom WS; Keum KC; Choi YD
Ann Surg Oncol; 2014 Nov; 21(12):4026-33. PubMed ID: 24841351
[TBL] [Abstract] [Full Text] [Related]
[Next]
